Citation: J. Mally et Tw. Stone, POTENTIAL OF ADENOSINE A(2A) RECEPTOR ANTAGONISTS IN THE TREATMENT OFMOVEMENT-DISORDERS, CNS drugs, 10(5), 1998, pp. 311-320
Authors:
EDER U
LEITNER B
KIRCHMAIR R
POHL P
JOBST KA
SMITH AD
MALLY J
BENZER A
RIEDERER P
REICHMANN H
SARIA A
WINKLER H
Citation: U. Eder et al., LEVELS AND PROTEOLYTIC PROCESSING OF CHROMOGRANIN-A AND CHROMOGRANIN-B AND SECRETOGRANIN-II IN CEREBROSPINAL-FLUID IN NEUROLOGICAL DISEASES, Journal of neural transmission, 105(1), 1998, pp. 39-51
Citation: J. Mally et Tw. Stone, REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION INDUCES AN IMPROVEMENT IN PARKINSONIAN SYMPTOMS, Medical science research, 26(8), 1998, pp. 521-523
Citation: J. Mally et al., SERUM AMINO-ACID LEVELS AS A POSSIBLE DIAGNOSTIC DIFFERENTIATION BETWEEN ESSENTIAL TREMOR AND PARKINSONIAN TREMOR, Medical science research, 25(8), 1997, pp. 519-520
Citation: J. Mally et al., CHANGES IN THE CONCENTRATION OF AMINO-ACIDS IN SERUM AND CEREBROSPINAL-FLUID OF PATIENTS WITH PARKINSONS-DISEASE, Journal of the neurological sciences, 151(2), 1997, pp. 159-162
Citation: J. Mally et al., CHANGE IN THE CONCENTRATIONS OF AMINO-ACIDS IN CSF AND SERUM OF PATIENTS WITH ESSENTIAL TREMOR, Journal of neural transmission, 103(5), 1996, pp. 555-560
Citation: J. Mally et Tw. Stone, POTENTIAL ROLE OF ADENOSINE ANTAGONIST THERAPY IN PATHOLOGICAL TREMORDISORDERS, Pharmacology & therapeutics, 72(3), 1996, pp. 243-250
Citation: J. Mally et al., DELAYED DEVELOPMENT OF SYMPTOMATIC IMPROVEMENT BY (-)-DEPRENYL IN PARKINSONS-DISEASE, Journal of the neurological sciences, 134(1-2), 1995, pp. 143-145
Citation: J. Mally et Tw. Stone, EFFICACY OF AN ADENOSINE ANTAGONIST, THEOPHYLLINE, IN ESSENTIAL TREMOR - COMPARISON WITH PLACEBO AND PROPRANOLOL, Journal of the neurological sciences, 132(2), 1995, pp. 129-132
Citation: J. Mally et M. Baranyi, CHANGE IN THE CONCENTRATIONS OF AMINO-ACIDS IN CISTERNAL CSF OF PATIENTS WITH ESSENTIAL TREMOR, Journal of Neurology, Neurosurgery and Psychiatry, 57(8), 1994, pp. 1012-1013
Citation: J. Mally et al., THEOPHYLLINE CONCENTRATIONS IN SERUM, SALIVA, AND CEREBROSPINAL-FLUIDIN PATIENTS WITH ESSENTIAL TREMOR, Therapeutic drug monitoring, 14(2), 1992, pp. 135-137